Disease Steps for Multiple Sclerosis
Evaluates MS disease progression based on patient’s ambulatory ability.
106 entries · Page 2 of 4
Evaluates MS disease progression based on patient’s ambulatory ability.
Predicts 3 month outcome in ischemic stroke patients receiving TPA.
Predicts which patients will benefit from prolonged DAPT after coronary stent placement.
Predicts likelihood that syncope is from cardiac cause.
Diagnoses embolic stroke of undetermined source.
Review ethosuximide pediatric dose by age group, including weight-based dosing for children under 6 and fixed dosing for older patients with absence epilepsy.
Describes severity of disability in patients with MS.
Rates risk of vasospasm in aSAH based on amount and distribution of blood on CT.
Grades coma severity; may be more accurate than the Glasgow Coma Scale.
Identifies patients with ICH who will attain functional independence and assists in clinical decision-making.
Combines GCS and pupil reactivity for greater accuracy at low GCS.
Predicts survival to discharge with good outcome after in-hospital cardiac arrest.
Stratifies severity of depression, similar to PHQ-9 .
Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.
Assesses hemorrhage risk after tPA.
Identifies potential stroke in patients with acute vestibular syndrome (AVS).
Classifies severity of subarachnoid hemorrhage to predict mortality.
Predicts 6-month mortality and unfavorable outcomes after moderate to severe traumatic brain injury (TBI).
Diagnoses Alzheimer disease (AD), newer than NINCDS-ADRDA Criteria .
Estimates mortality in ICH based on age and CT findings.
Diagnoses acute rheumatic fever based on major and minor criteria.
Evidence-based levetiracetam pediatric dose guide covering IV/PO loading, initial, and maintenance dosing for seizure management in children.
Diagnoses multiple sclerosis.
Measures the impact fatigue takes on a patient's daily life.
States severity of SAH based on amount and type of blood on CT with associated vasospasm risk.
Grades severity of symptoms in Parkinson disease.
Shortened, validated version of the NIHSS.
Measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.
Predicts short-term mortality in acute ischemic stroke.
No entries match your filter.